| Name | Fradiomycin Sulfate |
|---|---|
| Synonyms |
newfrancef
NEOMYCIN SULFATE 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)-β-D-ribofuranosyl]-D-strtamine Framycetin sulfate solution,100ppm quintess-n (2RS,3S,4S,5R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,5R,6R)-3,5-DIAMINO-2-((2R,3S,4R,5S)-3-AMINO-6-(AMINOMETHYL)-4,5-DIHYDROXYTETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMETHYL)TETRAHYDROFURAN-3-YLOXY)TETRAHYDRO-2H-PYRAN-3,4-DIOL otobiotic EINECS 215-773-1 NEOMYCIN SULPHATE 2000 ADE FRADIOMYCIN SULFATE Neomyacin B sulfate neomycinesulfate Neomycin trisulfate salt Neomycin sulfate, for microbiological assay NeoMycin Trisulfate NEOMYCIN TRISULFATE SALT HYDRATE, BIOTEC NEOMYCIN SULFATE PLANT CELL*CULTURE TEST ED (3S,4S,6R)-5-amino-2-(aminomethyl)-6-[(1S,2S,4R)-4,6-diamino-2-[[(2S,3S,5R)-4-[[(3S,4S,5R)-3-amino-6-(aminomethyl)-4,5-dihydroxy-2-oxanyl]oxy]-3-hydroxy-5-(hydroxymethyl)-2-oxolanyl]oxy]-3-hydroxycycl usafcb-19 NEOMYCIN.SULFATE ADE mycaifradinsulfate NeoMycin sulfat NEOMYCIN SULFATE CELL CULTURE TESTED neomix NEOMYCIN SOLUTION CELL CULTURE TESTED neofracin Neomycin Sulfate, γ-Irradiated, Tissue Culture ade NEOMYCIN, GAMMA IRRADIATED Neomycin Sulfate Tablets Neomycin sulfate 100mg [1-3] Framycetin sulfate solution,1000ppm MFCD00037007 Neomycin/sulfuric acid mycigient lidamycincreme O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.-)-O-.beta.-D-ribofuranosyl-(1-)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1-)]-2-deoxy sulfate Tilmicosin (FDA) Neomycin hydrate trisulfate salt neobiotic Dentgle NEOMYCIN SULFATE, GAMMA-IRRADIATED Neomycin Sulfate - - Calbiochem neo-mantlecreme 2'-DEOXYGUANOSINE MONOHYDRATE ULTRA biosolveteriny Neomycin Sulfate, γ-Irradiated, Tissue Culture ade - - Calbiochem Neomycin Sulfate NEOMYCIN SULFATE SALT FradioMycin Sulfate Neomycin Sulphate NeoMycin sulphate COS mycifradin-n (2S,3R,4R,5R)-5-amino-2-(aminomethyl)-6-[(2R,3R,4R,5S)-5-[(1S,2R,3S,5R,6S)-3,5-diamino-2-[(2R,3R,4R,5R,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxy-oxan-2-yl]oxy-6-hydroxy-cyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-oxane-3,4-diol sulfuric acid Neomyacin sulfate NEOMYCIN SULPHATE NeomycinSulphaturissForBacteriology Neomysin Sulphate NEOMYCIN SULFATE CELL CULTURE bykomycin Neomycin sulfate, an aminoglycoside antibiotic and calcium channel protein inhibitor Neomycin trisulfate hydrate Neomycin trisulfate salt hydrate |
| Description | Neomycin sulfate is an aminoglycoside antibiotic used for preventing or treating bacterial infections. |
|---|---|
| Related Catalog | |
| In Vitro | Neomycin inhibits thrombin-stimulated release of inositol 1,4,5-trisphosphate (IP3), by selectively binding PIP2, but does not inhibit 32P incorporation into PI or initiation of DNA synthesis[1]. Neomycin (10 μM-1 mM) induces considerable release of [3H]arachidonic acid from phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine in saponin-permeabilized human platelets prelabeled with [3H]arachidonic acid. Moreover, neomycin enhances arachidonic acid release induced by thrombin. Addition of neomycin (100 μM) to 45Ca2+-preloaded platelets elicits 45Ca2+ mobilizatioin from intracellular stores[2]. Neomycin (0-10 mM) inhibits guanosine 5'-[gamma-thio]triphosphate-stimulated PLD activity in digitonin-permeabilized NG108-15 cells in a concentration-dependent manner (50% inhibition at 100 μM). Neomycin similarly inhibits PLD activity present in rat brain membranes and assayed in vitro with [3H]phosphatidylcholine as substrate (50% inhibition at 65 μM)[3]. Neomycin (5 mM) causes reversible reductions in the level of intracellular Ca2+, but PtdIns(4,5)P2 is not required for the channel activity[4]. |
| References |
| Boiling Point | 1046.1ºC at 760 mmHg |
|---|---|
| Melting Point | >187°C (dec.) |
| Molecular Formula | C23H52N6O25S3 |
| Molecular Weight | 908.88 |
| Flash Point | 586.5ºC |
| PSA | 436.09000 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 56 ° (C=10, H2O) |
| Storage condition | 2-8°C |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Water Solubility | H2O: 50 mg/mL As a stock solution. Stock solutions should be filter sterilized and stored at 2-8°C. Stable at 37°C for 5 days. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H317-H334 |
| Precautionary Statements | P261-P280-P342 + P311 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | R42/43 |
| Safety Phrases | 23-36/37-45-22-36-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | QP4375000 |
| HS Code | 2941909000 |
| HS Code | 2941909000 |
|---|